Which investment firms are currently actively investing in new biomedical startups?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

Change history
26 November 2013
In the version of this article initially published, the Twitter contact was listed as @PureTechV. The correct contact is @PureTechH. The error has been corrected in the HTML and PDF versions of the article.
Acknowledgements
We would like to acknowledge Marco Mena, Megan Musacchio and Frank Zhu, who each provided critical research and analysis.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors are employed by PureTech Ventures (J.B. and P.M.) and Enlight Biosciences (J.B.).
Supplementary information
Supplementary Text and Figures
Supplementary Table 1 (PDF 111 kb)
Rights and permissions
About this article
Cite this article
Behr, J., Murray, P. In search of dry powder. Nat Biotechnol 31, 961–964 (2013). https://doi.org/10.1038/nbt.2729
Published:
Issue date:
DOI: https://doi.org/10.1038/nbt.2729
This article is cited by
-
Erratum: Corrigendum: In search of dry powder
Nature Biotechnology (2014)